Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan H Clarke

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
ACS Medicinal Chemistry Letters|August 25, 2020
Systematic Investigation of the Permeability of Androgen Receptor PROTACsDuncan E Scott, Timothy P C Rooney, Elliott D Bayle, et al.
The Plant Cell|March 5, 2003
DRL1, a homolog of the yeast TOT4/KTI12 protein, has a function in meristem activity and organ growth in plantsHilde Nelissen, Jonathan H Clarke, Marc De Block, et al.
RSC Medicinal Chemistry|October 20, 2023
The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K)Gregory G Aldred, Timothy P C Rooney, Henriette M G Willems, et al.
RSC Medicinal Chemistry|May 30, 2023
Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitorHenriëtte M G Willems, Simon Edwards, Helen K Boffey, et al.
ACS Medicinal Chemistry Letters|February 19, 2025
Development of the Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one Scaffold toward Potent and Selective NUAK1 InhibitorsTimothy P C Rooney, Gregory G Aldred, David Winpenny, et al.
Journal of Medicinal Chemistry|December 14, 2022
The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool MoleculesTimothy P C Rooney, Gregory G Aldred, Helen K Boffey, et al.
Journal of Medicinal Chemistry|February 11, 2022
Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding ModeHelen K Boffey, Timothy P C Rooney, Henriette M G Willems, et al.
Acta Neuropathologica|January 4, 2024
p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003Lewis W Taylor, Elizabeth M Simzer, Claire Pimblett, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
ACS Medicinal Chemistry Letters|August 25, 2020
Systematic Investigation of the Permeability of Androgen Receptor PROTACsDuncan E Scott, Timothy P C Rooney, Elliott D Bayle, et al.
The Plant Cell|March 5, 2003
DRL1, a homolog of the yeast TOT4/KTI12 protein, has a function in meristem activity and organ growth in plantsHilde Nelissen, Jonathan H Clarke, Marc De Block, et al.
RSC Medicinal Chemistry|October 20, 2023
The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K)Gregory G Aldred, Timothy P C Rooney, Henriette M G Willems, et al.
RSC Medicinal Chemistry|May 30, 2023
Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitorHenriëtte M G Willems, Simon Edwards, Helen K Boffey, et al.
ACS Medicinal Chemistry Letters|February 19, 2025
Development of the Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one Scaffold toward Potent and Selective NUAK1 InhibitorsTimothy P C Rooney, Gregory G Aldred, David Winpenny, et al.
Journal of Medicinal Chemistry|December 14, 2022
The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool MoleculesTimothy P C Rooney, Gregory G Aldred, Helen K Boffey, et al.
Journal of Medicinal Chemistry|February 11, 2022
Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding ModeHelen K Boffey, Timothy P C Rooney, Henriette M G Willems, et al.
Acta Neuropathologica|January 4, 2024
p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003Lewis W Taylor, Elizabeth M Simzer, Claire Pimblett, et al.
Pageof 3